Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Amortizatization of Intangibles: 2023-2025

Historic Amortizatization of Intangibles for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $816,000.

  • Immunome's Amortizatization of Intangibles fell 44.60% to $816,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 5.24%. This contributed to the annual value of $2.9 million for FY2024, which is 466.21% up from last year.
  • According to the latest figures from Q3 2025, Immunome's Amortizatization of Intangibles is $816,000, which was down 32.28% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Immunome's Amortizatization of Intangibles ranged from a high of $1.5 million in Q3 2024 and a low of -$442,000 during Q3 2023.
  • Its 3-year average for Amortizatization of Intangibles is $568,182, with a median of $538,000 in 2024.
  • In the last 5 years, Immunome's Amortizatization of Intangibles surged by 896.30% in 2024 and then plummeted by 44.60% in 2025.
  • Over the past 3 years, Immunome's Amortizatization of Intangibles (Quarterly) stood at $844,000 in 2023, then tumbled by 36.49% to $536,000 in 2024, then tumbled by 44.60% to $816,000 in 2025.
  • Its Amortizatization of Intangibles stands at $816,000 for Q3 2025, versus $1.2 million for Q2 2025 and $818,000 for Q1 2025.